BET inhibition reveals glycolytic vulnerability via HIF1α in triple-negative breast cancer
In a groundbreaking study poised to reshape the therapeutic landscape of aggressive breast cancers, researchers have uncovered a novel metabolic vulnerability in a specific subset...















